Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database

ConclusionPatients  ≥ 65 years with T2DM initiating sitagliptin tend to be older and have more comorbidities than those prescribed other classes of OAHA. Appropriate adjustment is required to minimize the impact of potential confounding and channeling bias in any comparative analyses including users of sitaglipti n.FundingMerck& Co., Inc., Kenilworth, NJ, USA.

Source: Diabetes Therapy - January 12, 2018 Category: Endocrinology Source Type: research